Hereditary degenerative retinopathies: optimism for somatic gene therapy

Area of Science:

• Ophthalmology
• Genetics
• Molecular Biology

Background:

• Retinitis pigmentosa (RP) is a large, heterogeneous group of inherited retinal disorders.
• Numerous primary genetic lesions have been identified worldwide.
• Some identified genes encode enzymes crucial to the retinal signal transduction pathway.

Purpose of the Study:

• To summarize current understanding of the genetic basis of retinitis pigmentosa.
• To explore the molecular mechanisms leading to retinal cell death in RP.
• To assess the potential of gene therapy for RP treatment.

Main Methods:

• In vitro functional assays.
• Transgenic and knock-out mouse models.
• Gene transfer studies in animal models.

Main Results:

• Genetic defects disrupt normal cell function through abnormal protein folding, metabolic errors, or membrane structural defects.
• These disruptions lead to gene-mediated cell death (apoptosis).
• Gene transfer approaches show potential for rescuing retinal degeneration in mouse models.

Conclusions:

• Recent research has significantly advanced the understanding of RP's heterogeneity and underlying mechanisms.
• Gene therapy holds promise as a future treatment strategy for retinitis pigmentosa.
• Further research is needed to address remaining questions and develop effective cures.